SHORT TIME DELIVERY OF STEMI PATIENTS TO PRIMARY PCI CENTERS
https://doi.org/10.17802/2306-1278-2013-1-44-51
Abstract
«Symptom – balloon» time is the cornerstone quality indicator of the national (regional) primary percutaneous coronary intervention (PPCI) network. Many reasons for PPCI delay require huge efforts of health professionals and the governing authorities to achieve the target result. The target «symptom – balloon» time can be less than 3 hours.
About the Author
V. I. Ganyukov
Federal State Budgetary Institution «Research Institute for Complex Issues of Cardiovascular Diseases under the Siberian Branch of the Russian Academy of Medical Sciences, Kemerovo
Russian Federation
Russian Federation
References
1. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) / S. C. Smith [et al.] //J. Am. Coll. Cardiol. 2006. Vol. 41. P. 1–121.
2. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients // Eur. Heart J. 2006. Vol. 27. P. 779–788.
3. Comparison of primary coronary angioplasty and TLT for AMI: a quantitative review / W. D. Weaver [et al.] // JAMA. 1997. Vol. 278. P. 2093.
4. ESC Guidelines for the management of acut myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology / H. G. Steg [et al.] // Eur. Heart J. 2012. Vol. 33 (20). P. 2569–2619.
5. Frequent reocclusion of patent IRA between 4 weeks and 1 year / H. D. White [et al.] // JACC. 1995. Vol. 25. P. 218.
6. How to set up an effective national primary angioplasty network: lessons learned from fi ve European countries / J. Knot [et al.] // EuroIntervention. 2009. Vol. 5(3). Р. 301–309.
7. Impact of the Romanian national programme for interventional therapy in ST-elevation myocardial infarction / G. Tatu-Chiţoiu1 [et al.] // EuroIntervention. 2012. Vol. 8. (Sup. P). P. 126–132.
8. Implementation of primary angio plasty in Europe: stent for life initiative progress report / S. D. Kristensen [et al.] // EuroIntervention. 2012. Vol. 8. P. 35–42.
9. Importance of IRA patency for recovery of LV function and late survival after PPCI / B. R. Brodie [et al.] // JACC. 1996. Vol. 28. P. 319.
10. Improvement in thtee-month angiographic outcome suggested after PCI for MI (Zwolle trial) compared with successful thrombolysis (APRICOT trial) / G. Veen [et al.] // Am. J. Cardiol. 1999. Vol. 84. P. 793.
11. Karamfi loff R., Jorgova J. Decreasing STEMI mortality by implementing a PPCI network in Bulgaria // EuroIntervention. 2012. Vol. 8. (Sup. P). P. 94–98.
12. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 randomized trials / E. C. Keeley [et al.] // Lancet. 2003. Vol. 361. P. 13–20.
13. Reduction of treatment delay in patients with ST- elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary inter vention / C. J. Terkelsen [et al.] // Eur. Heart J. 2005. Vol. 26. P. 770–777.
14. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time / J. M. Juliard [et al.] //Am. J. Cardiol. 2003. Vol. 91. P. 1401–1405.
15. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries / P. Widimsky [et al.] // Eur. Heart J. 2010. Vol. 31(8). Р. 943–957.
16. STEMI guidelines: from formulation to implementation / С. Di Mario [et al.] // EuroIntervention. 2012. Vol. 8. (Sup. P). P. 11–17.
17. Stent for Life Initiative – the Greek experience / J. Kanakakis [et al.] // EuroIntervention. 2012. Vol. 8. (Sup. P). P. 116–120.
18. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention / C. J. Terkelsen [et al.] // JAMA. 2010. Vol. 304. P. 763–771.
19. The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction. The GUSTO Angiographic Investigators. // N. Engl. J. Med. 1993. Vol. 329. P. 1615–1622.
20. Urban and rural implementation of pre-hospital diagnosis and direct referral for pri mary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction / J. T. Sørensen [et al.] // Eur. Heart J. 2011. Vol. 32. P. 430–436.
21. Variable penetration of primary angioplasty in Europe – what determines the implementation rate? / S. D. Kristensen [et al.] // EuroIntervention. 2012. Vol. 8. (Sup. P). P. 18–26.
22. Vienna STEMI Registry Group. Implementation of guidelines improves the stand ard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry) / K. Kalla [et al.] // Circulation. 2006. Vol. 113. P. 2398–2405.
Review
For citations:
Ganyukov V.I. SHORT TIME DELIVERY OF STEMI PATIENTS TO PRIMARY PCI CENTERS. Complex Issues of Cardiovascular Diseases. 2013;(1):44-51. (In Russ.) https://doi.org/10.17802/2306-1278-2013-1-44-51
Views:
616
